UCSF home page UCSF home page About UCSF UCSF Medical Center
Department of Medicine
Division of Infectious Diseases  
ID Home
Faculty & Staff
Education & Fellowship
Patient Care
Research
Ways to Give
Resources
ID Faculty

Harry Lampiris, M.D.
Professor of Clinical Medicine, UCSF
Interim Site Chief at the VA
Associate Program Director, UCSF
Infectious Disease Fellowship Training Program
harry.lampiris@va.gov

Mailing Address:
Department of Veterans Affairs Medical Center
4150 Clement Street, Box 111-W
San Francisco, CA 94121

Office Location:
VAMC San Francisco, Bldg 203, Room 1B-2

Research Interests:
Antiretroviral Therapy, Fungal Infections, Antimicrobial Therapy

Select Publications:

AR Zolopa, DS Berger, H Lampiris, L Zhong, SL Chuck, J Enejosa BP Kearney, AK Cheng.  2010.
Antiviral activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV-1: results of a phase 2, randomized, controlled, dose-ranging clinical trial.  J Infect Dis, in press.

H Hatano, H Lampiris, S Fransen, S Gupta, W Huang, R Hoh, JN Martin, J Lalezari, D Bangsberg, C Petropoulos, SG Deeks.  2010.  Long-term evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy.  JAIDS, in press.

G Fätkenheuer, M Nelson, A Lazzarin, I Konourina, A Hoepelman, H Lampiris, B. Hirschel, P Tebas, F Raffi, B Trottier, N Bellows, M Saag, DA Cooper, M Westby, M Tawadrous, C Ridgway, M Dunne, S Felstead, H Mayer, E van der Ryst.  2008.  Maraviroc in treatment-experienced CCR5-Tropic HIV-1 infected patients in MOTIVATE 1 and 2: week 48 pooled subgroup analysis of efficacy and safety.   N Engl J Med 359:1442-55.

PW Hunt, J Brenchley, E Sinclair, JM McCune, M Roland, K Page-Shafer, P Hsue, M Krone, H Lampiris, D Douek, JN Martin, and SG Deeks.  2008.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.  J Infect Dis 197:126-33.

T Shah, H Lampiris, M Vu, A Monto, and PC Tien.  2008.  Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual.  J Infect Dis 197:932-3.

Education and Training:

B.A., B.S., Brown University, 1981

M.D., University of California, San Francisco, 1985

Internal Medicine Residency, McGaw Medical Center of Northwestern University, 1985-1988

Infectious Disease Fellowship, University of California, San Francisco, 1989-1991


Home | Education | Patient Care | Research | Divisions | Giving | Webmaster
Copyright 2012 The Regents of the University of California